{"nct_id":"NCT02954406","title":"A Study of TAK-659 in Combination With Bendamustine (+/-Rituximab), Gemcitabine, Lenalidomide, or Ibrutinib for the Treatment of Participants With Advanced Non-Hodgkin Lymphoma","status":"TERMINATED","status_verified_date":"2021-12","start_date":"2017-03-05","start_date_type":"ACTUAL","primary_completion_date":"2020-07-27","primary_completion_date_type":"ACTUAL","completion_date":"2020-07-27","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["TAK"]}